title: Interleukin-2 receptor-directed immunosuppressive therapies: antibody- or cytokine-based targeting molecules.
authors: Department of Medicine, Beth Israel Hospital, Boston, MA.
authors: T B
authors: TB
authors: Strom
authors: V R
authors: VR
authors: Kelley
authors: T G
authors: TG
authors: Woodworth
authors: J R
authors: JR
authors: Murphy
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000628:therapy; D004353:Drug Evaluation, Preclinical; D006084:Graft Rejection / Q000628:therapy; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D000922:Immunotoxins / Q000627:therapeutic use; D015375:Receptors, Interleukin-2 / Q000037:antagonists & inhibitors / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D000922:Immunotoxins; D015375:Receptors, Interleukin-2